MONTEBIANCO ABENAVOLI, Ludovico
 Distribuzione geografica
Continente #
NA - Nord America 8.869
AS - Asia 7.588
EU - Europa 3.173
SA - Sud America 2.226
AF - Africa 187
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 19
Totale 22.115
Nazione #
US - Stati Uniti d'America 8.468
SG - Singapore 3.373
BR - Brasile 1.724
CN - Cina 1.654
IT - Italia 1.273
VN - Vietnam 969
IN - India 720
GB - Regno Unito 414
DE - Germania 334
SE - Svezia 330
CA - Canada 251
AR - Argentina 186
RU - Federazione Russa 151
HK - Hong Kong 143
FI - Finlandia 135
UA - Ucraina 125
EC - Ecuador 112
IR - Iran 104
MX - Messico 101
ID - Indonesia 98
NL - Olanda 90
TR - Turchia 84
BD - Bangladesh 82
CO - Colombia 62
ZA - Sudafrica 52
FR - Francia 48
PL - Polonia 48
PK - Pakistan 47
AU - Australia 46
IQ - Iraq 45
JP - Giappone 42
CL - Cile 40
PY - Paraguay 38
ES - Italia 32
RO - Romania 31
MA - Marocco 26
SA - Arabia Saudita 26
EG - Egitto 24
VE - Venezuela 23
KR - Corea 22
TW - Taiwan 22
DZ - Algeria 21
PE - Perù 21
UZ - Uzbekistan 21
AT - Austria 20
PH - Filippine 20
KE - Kenya 18
CZ - Repubblica Ceca 17
UY - Uruguay 15
RS - Serbia 14
CH - Svizzera 13
EU - Europa 13
HU - Ungheria 13
AZ - Azerbaigian 12
TH - Thailandia 12
IL - Israele 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
NG - Nigeria 10
NP - Nepal 10
DK - Danimarca 9
LT - Lituania 9
BH - Bahrain 8
HN - Honduras 8
IE - Irlanda 8
KZ - Kazakistan 8
SK - Slovacchia (Repubblica Slovacca) 8
BE - Belgio 7
LB - Libano 7
SN - Senegal 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
EE - Estonia 6
TN - Tunisia 6
BO - Bolivia 5
CR - Costa Rica 5
GT - Guatemala 5
JM - Giamaica 5
MD - Moldavia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BY - Bielorussia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
BB - Barbados 3
BW - Botswana 3
CG - Congo 3
CU - Cuba 3
ET - Etiopia 3
GR - Grecia 3
KW - Kuwait 3
LV - Lettonia 3
MM - Myanmar 3
MY - Malesia 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
Totale 22.071
Città #
San Jose 1.927
Singapore 863
Ashburn 787
Chandler 737
Dallas 630
Santa Clara 584
Hefei 548
Bengaluru 547
Milan 488
Princeton 421
Lawrence 419
Ho Chi Minh City 363
Chicago 325
London 277
Wilmington 260
Munich 227
Hanoi 209
Beijing 176
Ottawa 169
São Paulo 156
Des Moines 125
Hong Kong 122
Shanghai 82
Helsinki 72
New York 67
Boardman 66
Rome 61
Redwood City 60
Los Angeles 56
Rio de Janeiro 55
Turku 55
Catanzaro 54
Guayaquil 47
Brooklyn 45
Da Nang 45
Guangzhou 43
Haiphong 41
Curitiba 34
Norwalk 33
Brasília 32
Istanbul 31
Mumbai 31
Quito 31
Redmond 31
San Francisco 31
Assago 30
Biên Hòa 29
Kyiv 29
Salvador 28
Council Bluffs 26
Johannesburg 25
Belo Horizonte 24
Montreal 24
Warsaw 24
Bari 23
Moscow 23
Hanover 22
Chennai 21
Orem 21
Pune 21
Baghdad 20
Hải Dương 20
Mexico City 20
Amsterdam 19
Asunción 19
Bogotá 19
Boston 19
Naples 19
Porto Alegre 19
Shenzhen 19
Tokyo 19
Campinas 18
Santo André 18
Jakarta 17
St Petersburg 17
Tashkent 17
Turin 17
Dhaka 16
Goiânia 16
Jiaxing 15
Santiago 15
Stockholm 15
Taipei 15
Atlanta 14
Bologna 14
Joinville 14
Palermo 14
Phoenix 14
Recife 14
Sorocaba 14
Thái Bình 14
Zabki 14
Aversa 13
Buenos Aires 13
Can Tho 13
Guarulhos 13
Manchester 13
Montevideo 13
Phủ Lý 13
Ribeirão Preto 13
Totale 12.471
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 248
Combined Model for the Diagnosis of Hepatocellular Carcinoma: A Pilot Study Comparing the Liver to Spleen Volume Ratio and Liver Vein to Cava Attenuation 191
Efficacy and safety of fecal microbiota transplantation via colonoscopy as add-on therapy in patients with mild-to-moderate ulcerative colitis: A randomized clinical trial 131
Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. 130
The Use of Peppermint Oil in Gastroenterology 117
Milk thistle for non-alcoholic fatty liver disease treatment. 109
Abuso e dipendenza da alcol: principali aspetti internistici 108
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 107
Dietary polyphenolsand non-alcoholic fatty liver disease 106
Baclofen in the treatment of alcohol withdrawal syndrome: A comparative study vs diazepam 103
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 92
Noninvasive biochemical markers and surrogate scores in evaluating nonalcoholic steatohepatitis 91
Milk thistle in liver diseases: past, present, future. 84
Effects of Mediterranean diet supplemented with sylibin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease 80
Il craving nella dipendenza da alcol: dalla clinica al trattamento 80
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 79
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 78
Microbiome in Critical illness: An Unconventional and Unknown Ally. 78
Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders. 77
Kobyliak N, Abenavoli L, Mykhalchyshyn G, Kononenko L, Boccuto L, Kyriienko D, Dynnyk O. 76
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 74
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 73
An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD) 73
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 73
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 73
The role of gluten-free diet in nonalcoholic fatty liver disease development 73
A new mutation of the Wilson’s disease ATP7B gene and a genotype-phenotype correlation hypotheses. 71
Sudden olfactory loss as an early marker of COVID-19: a nationwide Italian survey 70
Evaluation of serum calprotectin as novel biomarker in psoriatic patients: a prospective pilot study 69
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 69
Gut Microbiota and Obesity: A Role for Probiotics 69
A case of alcohol delirium tremens rapidly suppressed by baclofen administration. 68
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 68
Celiac disease and hearing loss: a new association 67
L’epatopatia alcolica: dal danno alla terapia 67
SARS-CoV-2 Pandemic: Review of the Literature and Proposal for Safe Autopsy Practice 67
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 66
Ancient wheats: beneficial effects on insulin resistance 66
Adiponectin serum level changes and its dynamic relationship with hepatitis C during viral clearance. 65
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile 64
Affective disorders and quality of life in morbidly obese patients before and after bariatric surgery. 64
A Hazelnut-Enriched Diet Modulates Oxidative Stress and Inflammation Gene Expression without Weight Gain 64
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 64
A new mutation of Wilson’s disease P-type ATPase gene in a patient with cirrhosis and Coombs-positive haemolytic anemia 63
Milk thistle to treat non-alcoholic fatty liver disease: dream or reality? 63
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 63
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 63
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 62
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease 62
Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study 62
Alcohol consumption survey in an outpatient center of gastroenterology in southern Italy 62
Celiac disease and hearing loss. 62
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 62
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 61
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 61
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 60
Adiponectin levels in non-alcoholic fatty liver disease. 60
Acute alcohol intoxication 60
Effects of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infaction: statins for regeneration after acute myocardial and pci (strap) trial. 60
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 59
Baclofen in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus diazepam. 59
Affective and psychiatric disorders in celiac disease. 59
Gut microbiota and non-alcoholic fatty liver disease 59
Kambo: Natural drug or potential toxic agent? A literature review of acute poisoning cases 58
Wilson’s disease. Clinical, genetic and pharmacological findings. 58
C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention. 58
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 58
Non-alcoholic fatty liver disease and cardiovascular disease: a close relationship. 58
Effectiveness and Safety of A Nutraceutical Formulation for the Treatment of Functional Dyspepsia in Primary Care 58
Global multi-stakeholder endorsement of the MAFLD definition 57
Impact of Protein and Nutritional Support on the Muscular Status of Critically Ill Patients: A Pilot, Perspective, and Exploratory Study 57
The treatment of alcohol abuse and alcoholism: psychosocial and pharmacological management 57
Clinical evidence of the beneficial effects of baclofen in the treatment of alcohol dependence. 57
Phytotherapeutic approach to alcohol dependence: a new old way? A review 57
The relationship between the vitamin serum 25(OH)D and the B12 concentrations in obese women 57
Adiponectin in hepatology 57
Gastrointestinal symptoms, dietary regimen and anxiety levels during the COVID-19 pandemic among medical students: results from a web-based survey 57
Internal medicine Magna Græcia network for the management of hepatocellular carcinoma. 56
HCV antiviral therapy in injection drug users: difficult to treat or easy to cure? 56
A Systematic Review on Natural Antioxidant Properties of Resveratrol. 56
A mail questionnaire to 312 Italian Services on the use of complementary medicine in the treatment of alcoholism: survey on 7481 alcoholic patients. 56
The Effect of Alcohol on Gastrointestinal Motility. 55
Livelli di CXCR4, VEGFR e VLA-4 in linfociti di sangue periferico di pazienti con insufficienza epatica acuta su cronica trattati con G-CSF. 55
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 55
Serum Complement C3 and Type 2 Diabetes in Rheumatoid Arthritis: A Case-Control Study. 54
Efficacy of GHB and Baclofen in the treatment of alcohol addiction. 54
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 54
Variability in Phelan-McDermid syndrome: The impact of the PNPLA3 p.Ile148M polymorphism 54
Efficacia del beclometasone dipropionato in un caso di retto colite ulcerosa steroido-intollerante. 54
Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists 54
High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients 53
La steatosi epatica non alcolica nella pratica clinica: aspetti epidemiologici e inquadramento diagnostico 53
Warfarin interactions with medicinal herbs. 53
Epidemiology of Coronavirus Disease Outbreak: The Italian Trends. 53
Probiotics and gut health. 53
BRCA1-associated protein 1: Tumor predisposition syndrome and Kury-Isidor syndrome, from genotype-phenotype correlation to clinical management 52
Farmacoterapia dell’alcolismo: nuove evidenze 52
Basics in Endoscopic Ultrasound Part 1: Diagnostic Indications and Tissue Sampling. 52
The role of liver biopsy to assess non-alcoholic Fatty liver disease. 52
Terapia topica con 5ASA e Beclometasone Dipropionato in un caso di RCU moderata 52
Totale 7.006
Categoria #
all - tutte 219.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.906


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 17 21
2021/20221.271 37 34 27 281 92 26 46 298 126 85 171 48
2022/20232.788 857 82 84 219 230 201 91 218 372 185 205 44
2023/20241.643 256 201 90 91 71 319 73 179 121 51 92 99
2024/20254.928 747 416 209 196 210 641 136 144 718 412 329 770
2025/202611.158 391 1.229 1.400 2.611 1.018 363 1.305 692 1.388 585 176 0
Totale 22.634